A term sheet feels like the finish line. It is actually the starting gun on a relationship that could last ten years or more. The person signing that document will have more influence over your company — and your life — than almost anyone else you will ever work with.
The founders who regret their cap tables are rarely the ones who were cheated. They are the ones who didn't ask the right questions when they had the leverage to ask them.
"You are not just raising money. You are choosing a business partner who cannot be fired."
— Elodie MarchandThe Leverage Inversion Nobody Talks About
Here is the dynamic that most first-time founders don't fully appreciate until it's too late: the moment you accept a term sheet, your leverage in the relationship inverts. Before signing, you have options — other term sheets, other investors, the ability to walk away. After signing, your most important lever in any disagreement with your investor is your ability to credibly threaten to do exactly one thing: make their investment worth more. That is a much narrower lever than the one you had before.
This is why the due diligence questions that matter most are not the ones that come after you've decided to proceed. They are the ones you ask during the process — when both sides are still trying to impress each other, when the investor is competing for your deal rather than managing it, and when the answers to difficult questions can actually change your decision.
Most founders spend the fundraising process trying to pass investor due diligence. The ones who build the best partnerships spend it running their own.
The Questions About the Investor, Not the Fund
Institutional brand matters, but the person matters more. The partner who leads your deal is the one who will be in your board meetings, who will call you when things go wrong, and whose opinion will shape how the rest of the fund thinks about your company. "I'm backed by Accel" is not the same thing as "I'm backed by this specific partner at Accel who has done this successfully four times and whose founders universally describe as a genuine thought partner."
The first category of questions you should be asking are specifically about the person, not the firm. How many boards are they currently on? What happens to your deal if they leave the firm? Who will take over the relationship? Can you speak with two founders they backed whose companies did not achieve the expected outcome — not to find dirt, but to understand how they behave under pressure? The investors who are genuinely good at this welcome that last request. The ones who deflect it are telling you something important.
Ask them to describe a time they disagreed with a founder in their portfolio and were wrong. Not the diplomatic version — the real version, with specifics. Good investors have this story. They have learned from it. They can tell it without making the founder the villain. Investors who cannot produce this story are either not being honest with you or have not been in enough difficult situations to have learned from them.
The Questions About the Fund Itself
Where is the fund in its lifecycle? A fund that is two years into a ten-year vehicle has very different incentives than a fund that is eight years in and facing pressure to return capital to LPs. In the latter case, your investors may be less patient with the time required to build a genuinely durable company. They may push toward earlier exits than your optimal outcome. They may be more aggressive about mark-up rounds that look good on paper but create downstream valuation problems. None of this is malicious. It is structural. You need to understand it.
What is the fund's ownership target, and how does it affect your ability to bring in new investors? Some funds have pro-rata rights that give them the ability to maintain their percentage ownership in future rounds — which can be helpful if they exercise them supportively and harmful if they are strategic about blocking terms that disadvantage them. Ask specifically what happens in a scenario where a later-stage investor wants to lead your Series B at terms your existing investors consider unfavorable. How have they navigated that in the past?
What is the fund's explicit strategy around follow-on capital? Some funds reserve heavily for their best performers and support them aggressively through multiple rounds. Others deploy capital across a larger number of companies and expect founders to find external lead investors for subsequent rounds. Both models can work, but they create very different dynamics for the founder. You should know which model you're signing up for.
The Questions About the Relationship Under Stress
Everything works fine when things are going well. The relationship is tested when they're not. Before you sign, you should have a clear picture of what this investor does when a portfolio company misses its targets by a significant margin.
Ask them directly: "Tell me about a company in your portfolio that went through a serious crisis — missed revenue targets, leadership change, pivot, whatever — and walk me through what you did." The content of the answer matters. So does the speed at which they can access it. Investors who have been through multiple downturns with portfolio companies can give you this answer immediately and with texture. Investors who have only ever operated in a bull market will struggle.
Ask about their board meeting philosophy. Some investors use board meetings as performance reviews — structured around the metrics, focused on accountability, quick to move to judgment. Others use them as genuine strategic working sessions — messy, longer, focused on the hardest problems rather than the easiest metrics. Neither is universally better. The important thing is that it matches how you want to work. Ask to attend a board meeting at one of their portfolio companies before you sign. Very few investors will say no. The ones who do are telling you something.
The Questions About the Deal Itself
Most founders focus their negotiating energy on valuation. Valuation matters, but it is often the least important term in the sheet in the scenarios that determine actual founder outcomes. The terms that matter more are the ones that govern what happens when things don't go according to plan: liquidation preferences, participation rights, anti-dilution provisions, drag-along rights, and board composition.
Liquidation preferences determine who gets paid first in an exit. A 1x non-participating preference — the standard — means investors get their money back before founders and employees get anything, but do not participate further once that threshold is met. Participating preferences, or multiples above 1x, can dramatically change the math of what a "good" exit means for founders and early employees. Make sure you understand, with a spreadsheet and actual numbers, what different exit scenarios look like under the proposed terms. If your investor is not willing to walk you through this exercise, that is information.
Board composition is arguably the most consequential term in the sheet, and it receives far less negotiating attention than valuation. Who controls the board — and under what circumstances — determines who has the ultimate authority over major company decisions, including whether you remain CEO. The standard early-stage structure gives founders majority control through the Series A. Be very cautious about any arrangement that deviates from this without a compelling reason.
The questions you ask before signing are not just due diligence. They are the first demonstration to your investor of how you operate — the rigor you bring to important decisions, your willingness to ask difficult questions, and your ability to hold your own in a relationship that will be tested. The investors worth working with respect founders who ask hard questions. The ones who don't are not investors worth working with.